Big Pharma and academia cement big deals in the quest for bigger prizes With the patents of many highly profitable blockbuster drugs expiring over the course of a few years, the search is on for new drugs to fill large pharmaceutical companies’ shrinking product portfolios. For years, Big Pharma has turned to smaller biotech companies… Continue Reading
Tag Archives: pharma
The End of “Pay For Delay”?
Posted on from MoFo Tech Fall/Winter 2012More brand-name drug companies have been paying their competitors to delay their efforts to bring generic versions of blockbuster pharmaceuticals to market. The Federal Trade Commission estimates there were 28 “reverse payment” agreements in 2011—twice the number in 2007—involving 25 different branded pharmaceuticals with annual U.S. sales of more than $9 billion. A string of… Continue Reading
China: Innovation for Sale
Posted on from MoFo Tech Spring/Summer 2012The Chinese government has been encouraging overseas pharmaceutical companies to outsource R&D to Chinese firms—part of an effort to move into more high-value work. The draw: a growing, cost-effective bioscience talent pool made up of both local graduates and “sea turtles” who went to U.S. universities and returned, according to Morrison & Foerster partner Gordon… Continue Reading